LifeSci Advisors, LLC (LSA) Announces Investment Opinion on Neoprobe Corporation

Published: Mar 09, 2011

NEW YORK--(BUSINESS WIRE)--LifeSci Advisors, LLC, a leading provider of investment research and investor relations services in the life sciences sector, today announced that it has initiated coverage of Neoprobe Corporation (NYSE Amex: NEOP), a diversified developer of innovative oncology surgical and diagnostic products. Neoprobe is a world leader in gamma detection technology and is the only company marketing gamma detection devices working to optimize both radiotracers and gamma detection hardware.

Back to news